LIU, W.,
ZHUANG, R.,
BAI, X.,
JIA, Z.,
KAPORA, E.,
TAN, W.,
FENG, S. (2020) was observed to evaluate tumor formation in
vivo. Results: In our study, we showed that the expression of ASB16
of DHMEQ. In the present review, we describe mechanism of action, its in
vivo anticancer activity
PARFENOVA, L.V.,
LUKINA, E.S.,
GALIMSHINA, Z.R.,
GIL'FANOVA, G.U.,
MUKAEVA, V.R.,
FARRAKHOV, R.G.,
PARFENOV, E.V.,
DANILKO, K.V.,
DYAKONOV, G.S. (2020) or SMCC linkers can be recommended as promising candidates for further in
vivo research.
Yagudin, T.,
Zhao, Y.,
Gao, H.,
Zhang, Y.,
Yang, Y.,
Zhang, X.,
Ma, W.,
Daba, T.M.,
Ishmetov, V.,
Kang, K.,
Yang, B.,
Pan, Z. (2020) of iASPP was markedly reduced in the ischemic hearts in
vivo and hydrogen
peroxide
CAI, B.,
MA, W.,
WANG, X.,
SUKHAREVA, N.,
HUA, B.,
ZHANG, L.,
LI, X.,
LI, S.,
LIU, S.,
YU, M.,
XU, Y.,
SONG, R.,
XU, B.,
YANG, F.,
HAN, Z.,
DING, F.,
HUANG, Q.,
YU, Y.,
ZHAO, Y.,
WANG, J.,
BAMBA, D.,
PAN, Z.,
YANG, B.,
XU, J.,
ZAGIDULLIN, N.,
LI, F.,
TIAN, Y. (2020) apical resection. Conversely, in
vivo cardiac conditional knockout of LncDACH1 (CKO) and adenovirus